Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Serono, S.A.
Current Parent Company: Merck KGaA (EMD)
Parent at the Time of the Penalty Announcement:  subscribe to see this data field
Recap of Ownership Changes:  subscribe to see this data field
Penalty: $704,000,000
Year: 2005
Date: October 17, 2005
Offense Group: healthcare-related offenses
Primary Offense: off-label or unapproved promotion of medical products
Secondary Offense: False Claims Act and related
Mega-Scandal: Improper Drug Marketing
Violation Description: Swiss corporation, Serono, S.A., together with its U.S. subsidiaries and related entities, agreed to pay $704 million to resolve criminal charges and civil allegations in connection with illegal schemes to promote, market and sell its drug Serostim used to treat AIDS wasting, a condition involving profound involuntary weight loss in AIDS patients.
Level of Government: federal
Action Type: agency action
Agency: Justice Department Civil Division
Civil or Criminal Case: civil and criminal
HQ Country of Current Parent: Germany
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.